Abstract
Mexico City children are chronically exposed to significant concentrations of air pollutants and exhibit chronic respiratory-tract inflammation. Epidemiological, controlled human exposures, laboratory-based animal models, and in vitro/in vivo studies have shown that inflammatory, endothelial dysfunction, and endothelial damage mediators are upregulated upon exposure to particulate matter (PM). Endothelial dysfunction is a critical event in cardiovascular disease. The focus of thiswork was to investigate whether exposure to ambient air pollution including PM2.5 produces systemic inflammation and endothelial injury in healthy children. We measuredmarkers of endothelial activation, and inflammatory mediators in 52 children age 8.6±0.1 yr, residents of Mexico City (n: 28) or of Polotitlán (n: 24), a city with lowlevels of pollutants. Mexico City children had significant increases in inflammatory mediators and vasoconstrictors, including tumor necrosis factor (TNF)α, prostaglandin (PG) E2, C-reactive protein, interleukin-1β, and endothelin-1. There was a significant anti-inflammatory response, and a downregulation of vascular adhesion molecule-1, intercellular adhesion molecule-1 and -2, and selectins sE and sL. Results fromlinear regression found TNF a positively associated with 24- and 48-h cumulative levels of PM2.5, while the 7-d PM2.5 value was negatively associated with the numbers of white blood cells in peripheral blood in highly exposed children. Systemic subclinical inflammation, increased endothelin- 1, and significant downregulation of soluble adhesion molecules are seen in Mexico City children. Children chronically exposed to fine PM above the standard could be at risk of developing cardiovascular diseases, atherosclerosis, stroke, and other systemic effects later in life.
| Original language | English |
|---|---|
| Pages (from-to) | 499-506 |
| Number of pages | 8 |
| Journal | Inhalation Toxicology |
| Volume | 20 |
| Issue number | 5 |
| DOIs | |
| State | Published - Mar 2008 |
Funding
Grant support for this work was received from the National Science Foundation (0346458), the Montana Board of Research and Commercialization Technology Grant No. 04-06, 5 P20 RR015583, 1KO1 NS046410-01A1, 1R21-ES013293-01A1, and U.S. EPA CR829522. This work was presented in part at the American Thoracic Society 2007 Meeting at San Francisco by R. Villarreal-Calderon, who was awarded a 2007 Minority Trainee Travel Award. We express our gratitude to Raquel García, Eduardo Hernández-García, and Bernabé Santiago-Chávez at the National Institute of Pediatrics for their continuous technical support. Although the research described in this article has been funded wholly or in part by the U.S. Environmental Protection Agency through cooperative agreement CR829522 with the Center for Environmental Medicine, Asthma, and Lung Biology at the University of North Carolina at Chapel Hill, it has not been subjected to the agency’s required peer and policy review, and therefore does not necessarily reflect the views of the agency and no official endorsement should be inferred.
| Funders | Funder number |
|---|---|
| 0346458 | |
| K01NS046410 | |
| CR829522 | |
| University of North Carolina at Chapel Hill | |
| 1KO1 NS046410-01A1, 04-06, 1R21-ES013293-01A1, 5 P20 RR015583 |